Back to Journals » International Journal of Nanomedicine » Volume 6

Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions

Authors Tavares ER, Freitas FR, Diament JD, Maranhão RC

Published 12 October 2011 Volume 2011:6 Pages 2297—2304

DOI https://doi.org/10.2147/IJN.S24048

Review by Single-blind

Peer reviewer comments 2

Elaine R Tavares1, Fatima R Freitas1, Jayme Diament1, Raul C Maranhão1,2
1Heart Institute of the Medical School Hospital (InCor), University of São Paulo, São Paulo, Brazil; 2Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil

Objectives: Cholesterol-rich nanoemulsions (LDE) bind to low-density lipoprotein (LDL) receptors and after injection into the bloodstream concentrate in aortas of atherosclerotic rabbits. Association of paclitaxel with LDE markedly reduces the lesions. In previous studies, treatment of refractory cancer patients with etoposide associated with LDE had been shown devoid of toxicity. In this study, the ability of etoposide to reduce lesions and inflammatory factors in atherosclerotic rabbits was investigated.
Methods: Eighteen New Zealand rabbits were fed a 1% cholesterol diet for 60 days. Starting from day 30, nine animals were treated with four weekly intravenous injections of etoposide oleate (6 mg/kg) associated with LDE, and nine control animals were treated with saline solution injections.
Results: LDE-etoposide reduced the lesion areas of cholesterol-fed animals by 85% and intima width by 50% and impaired macrophage and smooth muscle cell invasion of the intima. Treatment also markedly reduced the protein expression of lipoprotein receptors (LDL receptor, LDL-related protein-1, cluster of differentiation 36, and scavenger receptor class B member 1), inflammatory cytokines (interleukin-1β and tumor necrosis factor-α), matrix metallopeptidase-9, and cell proliferation markers (topoisomerase IIα and tubulin).
Conclusion: The ability of LDE-etoposide to strongly reduce the lesion area and the inflammatory process warrants the great therapeutic potential of this novel preparation to target the inflammatory-proliferative basic mechanisms of the disease.

Keywords: atherosclerosis treatment, drug delivery, LDL-receptors

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats

Maranhão RC, Guido MC, de Lima AD, Tavares ER, Marques AF, Tavares de Melo MD, Nicolau JC, Salemi VMC, Kalil-Filho R

International Journal of Nanomedicine 2017, 12:3767-3784

Published Date: 17 May 2017

Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice

Kretzer IF, Maria DA, Guido MC, Contente TC, Maranhão RC

International Journal of Nanomedicine 2016, 11:885-904

Published Date: 7 March 2016

Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis

Mello SB, Tavares ER, Bulgarelli A, Bonfá E, Maranhão RC

International Journal of Nanomedicine 2013, 8:443-449

Published Date: 14 February 2013

Novel formulation of a methotrexate derivative with a lipid nanoemulsion

Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhao RC

International Journal of Nanomedicine 2011, 6:2285-2295

Published Date: 12 October 2011

Readers of this article also read:

Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells

Shi S, Jia J, Guo X, Zhao Y, Chen D, Guo Y, Cheng T, Zhang X

International Journal of Nanomedicine 2012, 7:5593-5602

Published Date: 25 October 2012

Biofunctionalization of a titanium surface with a nano-sawtooth structure regulates the behavior of rat bone marrow mesenchymal stem cells

Zhang WJ, Li ZH, Liu Y, Ye DX, Li JH, Xu LY, Wei B, Zhang XL, Liu XY, Jiang XQ

International Journal of Nanomedicine 2012, 7:4459-4472

Published Date: 13 August 2012

Acceleration of gene transfection efficiency in neuroblastoma cells through polyethyleneimine/poly(methyl methacrylate) core-shell magnetic nanoparticles

Tencomnao T, Klangthong K, Pimpha N, Chaleawlert-umpon S, Saesoo S, Woramongkolchai N, Saengkrit N

International Journal of Nanomedicine 2012, 7:2783-2792

Published Date: 1 June 2012

The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals

Men Y, Wang XX, Li RJ, Zhang Y, Tian W, Yao HJ, Ju RJ, Ying X, Zhou J, Li N, Zhang L, Yu Y, Lu WL

International Journal of Nanomedicine 2011, 6:3125-3137

Published Date: 2 December 2011

Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers

Fazlollahi F, Sipos A, Kim YH, Hamm-Alvarez SF, Borok Z, Kim K-J, Crandall ED

International Journal of Nanomedicine 2011, 6:2849-2857

Published Date: 10 November 2011

Uptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophages

Perez AP, Cosaka ML, Romero EL, Morilla MJ

International Journal of Nanomedicine 2011, 6:2715-2728

Published Date: 4 November 2011

Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays

Yang XQ, Chen C, Peng CW, Hou JX, Liu SP, Qi CB, Gong YP, Zhu XB, Pang DW, Li Y

International Journal of Nanomedicine 2011, 6:2265-2273

Published Date: 11 October 2011

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs

Axiak SM, Selting KA, Decedue CJ, Henry CJ, Tate D, Howell J, Bilof KJ, Kim DY

International Journal of Nanomedicine 2011, 6:2205-2212

Published Date: 11 October 2011

Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells

Diao YY, Li HY, Fu YH, Han M, Hu YL, Jiang HL, Tsutsumi Y, Wei QC, Chen DW, Gao JQ

International Journal of Nanomedicine 2011, 6:1955-1962

Published Date: 12 September 2011